Glucocorticoid	B-protein
receptors	I-protein
in	O
normal	B-cell_type
leukocytes	I-cell_type
:	O
effects	O
of	O
age	O
,	O
gender	O
,	O
season	O
,	O
and	O
plasma	O
cortisol	O
concentrations	O
.	O

We	O
measured	O
glucocorticoid	B-protein
receptors	I-protein
(	O
GR	B-protein
)	O
in	O
mononuclear	B-cell_type
leukocytes	I-cell_type
(	O
MNL	B-cell_type
)	O
isolated	O
from	O
peripheral	O
blood	O
of	O
145	O
apparently	O
healthy	O
volunteers	O
(	O
86	O
men	O
and	O
59	O
women	O
)	O
.	O

An	O
age-related	O
decrease	O
in	O
the	O
number	O
of	O
GR	B-protein
was	O
suggested	O
between	O
subjects	O
younger	O
than	O
20	O
years	O
and	O
elderly	O
subjects	O
;	O
there	O
was	O
no	O
apparent	O
seasonal	O
variation	O
in	O
GR	B-protein
.	O

Gender	O
difference	O
in	O
the	O
number	O
of	O
GR	B-protein
was	O
not	O
significant	O
,	O
although	O
women	O
showed	O
slightly	O
fewer	O
GR	B-protein
.	O

Eight	O
patients	O
with	O
dermatomyositis/polymyositis	O
were	O
examined	O
to	O
determine	O
whether	O
the	O
number	O
of	O
GR	B-protein
in	O
MNL	B-cell_type
could	O
be	O
down-regulated	O
by	O
their	O
cognate	O
ligands	O
.	O

The	O
number	O
of	O
GR	B-protein
in	O
MNL	B-cell_type
from	O
these	O
patients	O
was	O
significantly	O
decreased	O
one	O
month	O
after	O
the	O
initiation	O
of	O
prednisolone	O
therapy	O
.	O

However	O
,	O
in	O
normal	O
subjects	O
,	O
the	O
GR	B-protein
in	O
MNL	B-cell_type
did	O
not	O
demonstrate	O
circadian	O
variation	O
,	O
in	O
contrast	O
to	O
concentrations	O
of	O
plasma	O
cortisol	O
.	O

CLIN	NULL
.	NULL

CHEM	NULL
.	NULL

37/10	NULL
,	NULL
1715-1719	NULL
(	NULL
1991	NULL
)	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Normal	NULL
Leukocytes	NULL
:	NULL
Effects	NULL
of	NULL
Age	NULL
,	NULL
Gender	NULL
,	NULL
Season	NULL
,	NULL
and	NULL
Plasma	NULL
Cortisol	NULL
Concentrations	NULL
Hirotoshi	NULL
Tanaka	NULL
,	NULL
``	NULL
Hideto	NULL
Akama	NULL
,	NULL
Yoichi	NULL
Ichikawa	NULL
,	NULL
Mitsuo	NULL
Homma	NULL
,	NULL
and	NULL
Hisaji	NULL
Oshima	NULL
?	NULL

We	NULL
measured	NULL
glucocorticoid	NULL
receptors	NULL
(	NULL
GR	NULL
)	NULL
in	NULL
mononuclear	NULL
leukocytes	NULL
(	NULL
MNL	NULL
)	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
145	NULL
apparently	NULL
healthy	NULL
volunteers	NULL
(	NULL
86	NULL
men	NULL
and	NULL
59	NULL
wom-en	NULL
)	NULL
.	NULL

An	NULL
age-related	NULL
decrease	NULL
in	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
was	NULL
suggested	NULL
between	NULL
subjects	NULL
younger	NULL
than	NULL
20	NULL
years	NULL
and	NULL
elderly	NULL
subjects	NULL
;	NULL
there	NULL
was	NULL
no	NULL
apparent	NULL
seasonal	NULL
variation	NULL
in	NULL
GR	NULL
.	NULL

Gender	NULL
difference	NULL
in	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
was	NULL
not	NULL
significant	NULL
,	NULL
although	NULL
women	NULL
showed	NULL
slightly	NULL
fewer	NULL
GR	NULL
.	NULL

Eight	NULL
patients	NULL
with	NULL
dermatomyositis/polymyositis	NULL
were	NULL
examined	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
in	NULL
MNL	NULL
could	NULL
be	NULL
down-regulated	NULL
by	NULL
their	NULL
cognate	NULL
ligands	NULL
.	NULL

The	NULL
number	NULL
of	NULL
GR	NULL
in	NULL
MNL	NULL
from	NULL
these	NULL
patients	NULL
was	NULL
significantly	NULL
decreased	NULL
one	NULL
month	NULL
after	NULL
the	NULL
initiation	NULL
of	NULL
prednisolone	NULL
therapy	NULL
.	NULL

However	NULL
,	NULL
in	NULL
normal	NULL
subjects	NULL
,	NULL
the	NULL
GR	NULL
in	NULL
MNL	NULL
did	NULL
not	NULL
demonstrate	NULL
circadian	NULL
variation	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
concentrations	NULL
of	NULL
plasma	NULL
cortisol	NULL
.	NULL

Additional	NULL
Keyphrases	NULL
:	NULL
sex-	NULL
and	NULL
age-related	NULL
effects	NULL
-	NULL
derma-	NULL
tomyositis/polymyositis	NULL
+	NULL
prednisolone	NULL
therapy	NULL
Glucocorticoids	NULL
exert	NULL
numerous	NULL
biological	NULL
effects	NULL
on	NULL
various	NULL
cellular	NULL
and	NULL
metabolic	NULL
processes	NULL
.	NULL

On	NULL
entry	NULL
into	NULL
target	NULL
cells	NULL
,	NULL
they	NULL
interact	NULL
with	NULL
specific	NULL
intracellular	NULL
proteins	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
glucocorticoid	NULL
receptors	NULL
(	NULL
GR	NULL
)	NULL
;	NULL
the	NULL
GR	NULL
then	NULL
undergo	NULL
a	NULL
conformational	NULL
change	NULL
that	NULL
enables	NULL
a	NULL
receptor	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
bind	NULL
to	NULL
specific	NULL
acceptor	NULL
sites	NULL
of	NULL
DNA	NULL
.	NULL

The	NULL
GR	NULL
thereby	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
target	NULL
genes	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
cascade	NULL
of	NULL
biological	NULL
events	NULL
(	NULL
reviewed	NULL
in	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Abundant	NULL
evidence	NULL
has	NULL
already	NULL
been	NULL
accumulated	NULL
suggesting	NULL
the	NULL
importance	NULL
of	NULL
GR	NULL
determination	NULL
in	NULL
assessing	NULL
therapeutic	NULL
responsiveness	NULL
to	NULL
glucocorticoids	NULL
in	NULL
patients	NULL
with	NULL
heterologous	NULL
diseases	NULL
and	NULL
in	NULL
healthy	NULL
humans	NULL
(	NULL
3-9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
become	NULL
apparent	NULL
that	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
and	NULL
glucocorticoid	NULL
responsiveness	NULL
is	NULL
not	NULL
always	NULL
consistent	NULL
,	NULL
the	NULL
reason	NULL
for	NULL
which	NULL
is	NULL
still	NULL
unclear	NULL
.	NULL

Moreover	NULL
,	NULL
as	NULL
previously	NULL
re-ported	NULL
,	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
shows	NULL
wide	NULL
variation	NULL
,	NULL
attributable	NULL
to	NULL
differences	NULL
in	NULL
assay	NULL
procedures	NULL
or	NULL
conditions	NULL
(	NULL
3-16	NULL
)	NULL
,	NULL
which	NULL
has	NULL
made	NULL
it	NULL
extremely	NULL
difficult	NULL
to	NULL
compare	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Keio	NULL
University	NULL
,	NULL
Shinjuku-ku	NULL
,	NULL
Tokyo	NULL
160	NULL
,	NULL
Japan	NULL
.	NULL

*	NULL
Present	NULL
address	NULL
(	NULL
and	NULL
address	NULL
for	NULL
correspondence	NULL
)	NULL
:	NULL
The	NULL
Second	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Asahikawa	NULL
Medical	NULL
College	NULL
,	NULL
Nishikagura-4-5	NULL
,	NULL
Asahikawa	NULL
078	NULL
,	NULL
Japan	NULL
.	NULL

*Present	NULL
address	NULL
:	NULL
Steroid	NULL
Hormone	NULL
Section	NULL
,	NULL
Department	NULL
of	NULL
Health	NULL
and	NULL
Human	NULL
Services	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Be-theada	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

®	NULL
Nonstandard	NULL
abbreviations	NULL
:	NULL
GR	NULL
,	NULL
glucocorticoid	NULL
receptors	NULL
;	NULL
MNL	NULL
,	NULL
mononuclear	NULL
leukocytes	NULL
;	NULL
R.	NULL
,	NULL
...	NULL
number	NULL
of	NULL
specific	NULL
binding	NULL
sites	NULL
.	NULL

Received	NULL
February	NULL
19	NULL
,	NULL
1991	NULL
;	NULL
accepted	NULL
August	NULL
9	NULL
,	NULL
1991.	NULL
independently	NULL
performed	NULL
studies	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
contents	NULL
of	NULL
GR	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
critical	NULL
in	NULL
predicting	NULL
the	NULL
magnitude	NULL
of	NULL
hormone	NULL
effects	NULL
in	NULL
various	NULL
diseases	NULL
,	NULL
but	NULL
that	NULL
is	NULL
not	NULL
sufficiently	NULL
proven	NULL
yet	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
because	NULL
of	NULL
variation	NULL
in	NULL
the	NULL
GR	NULL
assay	NULL
itself	NULL
.	NULL

We	NULL
have	NULL
already	NULL
established	NULL
a	NULL
simple	NULL
whole-cell	NULL
assay	NULL
of	NULL
GR	NULL
in	NULL
human	NULL
mononuclear	NULL
leukocytes	NULL
(	NULL
MNL	NULL
)	NULL
(	NULL
9	NULL
)	NULL
and	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
in	NULL
normal	NULL
human	NULL
MNL	NULL
correlates	NULL
to	NULL
hormone	NULL
responsiveness	NULL
both	NULL
in	NULL
vivo	NULL
(	NULL
9	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
Ia	NULL
)	NULL
.	NULL

To	NULL
further	NULL
verify	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
assay	NULL
procedure	NULL
with	NULL
regard	NULL
to	NULL
clinical	NULL
application	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
a	NULL
relatively	NULL
large	NULL
,	NULL
apparently	NULL
healthy	NULL
population	NULL
to	NULL
examine	NULL
age-	NULL
or	NULL
gender-related	NULL
and	NULL
seasonal	NULL
and	NULL
diurnal	NULL
variations	NULL
in	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
in	NULL
normal	NULL
human	NULL
MNL	NULL
.	NULL

Subjects	NULL
and	NULL
Sampling	NULL
Subjects	NULL
were	NULL
145	NULL
apparently	NULL
healthy	NULL
volunteers	NULL
:	NULL
86	NULL
men	NULL
,	NULL
ages	NULL
18-79	NULL
years	NULL
(	NULL
mean	NULL
24.2	NULL
,	NULL
SD	NULL
35.1	NULL
)	NULL
,	NULL
59	NULL
women	NULL
,	NULL
ages	NULL
18-77	NULL
years	NULL
(	NULL
mean	NULL
32.3	NULL
,	NULL
SD	NULL
31.8	NULL
)	NULL
,	NULL
and	NULL
eight	NULL
women	NULL
with	NULL
dermatomyositis/polymyositis	NULL
,	NULL
ages	NULL
19-36	NULL
years	NULL
(	NULL
mean	NULL
23.5	NULL
,	NULL
SD	NULL
11.1	NULL
)	NULL
.	NULL

Blood	NULL
was	NULL
drawn	NULL
into	NULL
heparinized	NULL
tubes	NULL
by	NULL
antecu-bital	NULL
venous	NULL
puncture	NULL
,	NULL
generally	NULL
at	NULL
0800	NULL
h	NULL
after	NULL
an	NULL
overnight	NULL
fast	NULL
,	NULL
with	NULL
two	NULL
consecutive	NULL
blood	NULL
samplings	NULL
at	NULL
15-min	NULL
intervals	NULL
(	NULL
the	NULL
volumes	NULL
of	NULL
blood	NULL
drawn	NULL
were	NULL
60	NULL
,	NULL
5	NULL
,	NULL
and	NULL
5	NULL
mL	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

MNL	NULL
were	NULL
isolated	NULL
,	NULL
without	NULL
delay	NULL
,	NULL
from	NULL
55	NULL
mL	NULL
of	NULL
the	NULL
initially	NULL
collected	NULL
blood	NULL
sample	NULL
and	NULL
analyzed	NULL
for	NULL
GR	NULL
.	NULL

Plasma	NULL
was	NULL
separated	NULL
from	NULL
5	NULL
mL	NULL
of	NULL
each	NULL
blood	NULL
collection	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
determination	NULL
of	NULL
cortisol	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Chemicals	NULL
.	NULL

[	NULL
6,7-°H	NULL
]	NULL
Dexamethasone	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
47.5	NULL
kCi/mol	NULL
)	NULL
and	NULL
[	NULL
1,2-	NULL
%	NULL
HJcortisol	NULL
(	NULL
40	NULL
kCi/mol	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Nuclear	NULL
(	NULL
NEN	NULL
)	NULL
Research	NULL
Products	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL

Unlabeled	NULL
dexamethasone	NULL
was	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
.	NULL

Ficoll	NULL
400	NULL
was	NULL
from	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
.	NULL

Hypaque	NULL
was	NULL
from	NULL
Winthrop	NULL
Labs	NULL
.	NULL

,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

RPMI-1640	NULL
medium	NULL
and	NULL
fetal	NULL
calf	NULL
serum	NULL
were	NULL
from	NULL
Gibco	NULL
BRL	NULL
Labs	NULL
.	NULL

,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

Cell	NULL
preparations	NULL
.	NULL

Whole	NULL
blood	NULL
was	NULL
fractionated	NULL
by	NULL
one-step	NULL
gradient	NULL
centrifugation	NULL
with	NULL
Ficoll	NULL
(	NULL
80.2	NULL
g/L	NULL
)	NULL
-Hypaque	NULL
(	NULL
1.077	NULL
kg/L	NULL
)	NULL
at	NULL
400	NULL
x	NULL
g	NULL
for	NULL
30	NULL
min	NULL
at	NULL
20	NULL
°C	NULL
.	NULL

The	NULL
MNL-enriched	NULL
interphase	NULL
was	NULL
washed	NULL
twice	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
then	NULL
resuspended	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
and	NULL
used	NULL
as	NULL
MNL	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Viability	NULL
of	NULL
cells	NULL
exceeded	NULL
95	NULL
%	NULL
during	NULL
the	NULL
experiments	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
.	NULL

Whole-cell	NULL
assay	NULL
of	NULL
GR	NULL
.	NULL

Cell	NULL
counts	NULL
were	NULL
adjusted	NULL
to	NULL
1	NULL
x	NULL
10'°°	NULL
%	NULL
/L	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
and	NULL
the	NULL
GR	NULL
were	NULL
CLINICAL	NULL
CHEMISTRY	NULL
,	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

10	NULL
,	NULL
1991	NULL
1715	NULL
determined	NULL
essentially	NULL
as	NULL
described	NULL
before	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
200	NULL
uL	NULL
of	NULL
suspension	NULL
was	NULL
added	NULL
to	NULL
all	NULL
tubes	NULL
,	NULL
which	NULL
had	NULL
previously	NULL
received	NULL
50	NULL
uL	NULL
of	NULL
RPMI-1640	NULL
medium	NULL
containing	NULL
[	NULL
°H	NULL
}	NULL
dexamethasone	NULL
at	NULL
final	NULL
concentrations	NULL
of	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
2.5	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
20	NULL
,	NULL
and	NULL
40	NULL
nmol/L	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
or	NULL
without	NULL
a	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
dexa-methasone	NULL
.	NULL

All	NULL
tubes	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
with	NULL
gentle	NULL
shaking	NULL
for	NULL
2	NULL
h.	NULL
Then	NULL
,	NULL
200	NULL
uL	NULL
of	NULL
suspension	NULL
was	NULL
transferred	NULL
into	NULL
a	NULL
microcentrifuge	NULL
tube	NULL
(	NULL
Microfuge*	NULL
``	NULL
;	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
containing	NULL
150	NULL
uL	NULL
of	NULL
silicone	NULL
oil	NULL
cushion	NULL
.	NULL

After	NULL
centrifuging	NULL
the	NULL
sample	NULL
at	NULL
10	NULL
000	NULL
x	NULL
z	NULL
for	NULL
45	NULL
s	NULL
,	NULL
we	NULL
cut	NULL
off	NULL
the	NULL
bottom	NULL
tip	NULL
of	NULL
tube	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
cell	NULL
pellet	NULL
,	NULL
and	NULL
placed	NULL
this	NULL
in	NULL
a	NULL
scintillation	NULL
counting	NULL
vial	NULL
.	NULL

The	NULL
radioactivity	NULL
of	NULL
the	NULL
pellet	NULL
was	NULL
counted	NULL
in	NULL
10	NULL
mL	NULL
of	NULL
Aquasol	NULL
(	NULL
NEN	NULL
Research	NULL
Products	NULL
)	NULL
with	NULL
a	NULL
Beckman	NULL
Model	NULL
LS-9800	NULL
scintillation	NULL
counter	NULL
,	NULL
which	NULL
has	NULL
an	NULL
average	NULL
efficiency	NULL
of	NULL
40	NULL
%	NULL
for	NULL
tritium	NULL
.	NULL

All	NULL
determinations	NULL
were	NULL
performed	NULL
in	NULL
tripli-cate	NULL
.	NULL

The	NULL
apparent	NULL
dissociation	NULL
constant	NULL
(	NULL
K	NULL
,	NULL
,	NULL
)	NULL
and	NULL
the	NULL
number	NULL
of	NULL
specific	NULL
binding	NULL
sites	NULL
(	NULL
R.	NULL
,	NULL
...	NULL
)	NULL
were	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Radioimmunoassay	NULL
of	NULL
plasma	NULL
cortisol	NULL
.	NULL

We	NULL
measured	NULL
cortisol	NULL
in	NULL
plasma	NULL
in	NULL
duplicate	NULL
by	NULL
radioimmunoassay	NULL
(	NULL
18	NULL
)	NULL
and	NULL
then	NULL
calculated	NULL
the	NULL
mean	NULL
value	NULL
.	NULL

The	NULL
detection	NULL
limit	NULL
of	NULL
the	NULL
assay	NULL
was	NULL
3	NULL
nmol/L	NULL
.	NULL

The	NULL
intra-	NULL
and	NULL
interas-say	NULL
CVs	NULL
were	NULL
<	NULL
10	NULL
%	NULL
and	NULL
<	NULL
17	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

Linear	NULL
regression	NULL
and	NULL
correlation	NULL
were	NULL
calculated	NULL
by	NULL
the	NULL
least-squares	NULL
method	NULL
.	NULL

For	NULL
comparison	NULL
of	NULL
two	NULL
variables	NULL
,	NULL
we	NULL
used	NULL
Student	NULL
's	NULL
¢-test	NULL
,	NULL
paired	NULL
or	NULL
unpaired	NULL
where	NULL
appropriate	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
unless	NULL
otherwise	NULL
specified	NULL
.	NULL

Results	NULL
Whole-cell	NULL
assay	NULL
for	NULL
GR	NULL
in	NULL
normal	NULL
human	NULL
MNL	NULL
.	NULL

R	NULL
...	NULL
,	NULL
and	NULL
K	NULL
,	NULL
,	NULL
were	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
,	NULL
and	NULL
individual	NULL
R	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
results	NULL
were	NULL
used	NULL
as	NULL
the	NULL
GR	NULL
number	NULL
of	NULL
the	NULL
corresponding	NULL
subject	NULL
.	NULL

In	NULL
five	NULL
subjects	NULL
,	NULL
GR	NULL
determination	NULL
was	NULL
repeated	NULL
five	NULL
times	NULL
in	NULL
separate	NULL
experiments	NULL
,	NULL
and	NULL
the	NULL
intra-assay	NULL
CV	NULL
was	NULL
calculated	NULL
for	NULL
R	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
and	NULL
K	NULL
,	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
CV	NULL
for	NULL
R.	NULL
,	NULL
,	NULL
,	NULL
ranged	NULL
from	NULL
0.6	NULL
%	NULL
to	NULL
26.1	NULL
%	NULL
(	NULL
mean	NULL
9.8	NULL
%	NULL
)	NULL
,	NULL
and	NULL
the	NULL
CV	NULL
for	NULL
K	NULL
,	NULL
from	NULL
4.4	NULL
%	NULL
to	NULL
39.2	NULL
%	NULL
(	NULL
mean	NULL
15.9	NULL
%	NULL
)	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Effects	NULL
of	NULL
age	NULL
,	NULL
gender	NULL
,	NULL
and	NULL
time	NULL
of	NULL
year	NULL
on	NULL
number	NULL
of	NULL
GR	NULL
in	NULL
MNL	NULL
.	NULL

In	NULL
145	NULL
healthy	NULL
subjects	NULL
,	NULL
the	NULL
range	NULL
of	NULL
R	NULL
...	NULL
,	NULL
was	NULL
2.5-16.4	NULL
fmol/10°	NULL
cells	NULL
(	NULL
8.5	NULL
+	NULL
2.5	NULL
,	NULL
mean	NULL
+	NULL
SD	NULL
)	NULL
,	NULL
and	NULL
K	NULL
,	NULL
was	NULL
2.2-15.8	NULL
nmol/L	NULL
(	NULL
6.8	NULL
+	NULL
2.3	NULL
)	NULL
.	NULL

When	NULL
the	NULL
GR	NULL
Table	NULL
1	NULL
.	NULL

Precision	NULL
of	NULL
Whole-Cell	NULL
Assay	NULL
of	NULL
number	NULL
was	NULL
determined	NULL
,	NULL
we	NULL
plotted	NULL
the	NULL
individual	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
against	NULL
age	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
significant	NULL
correlation	NULL
between	NULL
GR	NULL
number	NULL
and	NULL
age	NULL
(	NULL
r	NULL
=	NULL
-0.122	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
subjects	NULL
were	NULL
divided	NULL
into	NULL
four	NULL
groups	NULL
by	NULL
age	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
,	NULL
group	NULL
B	NULL
(	NULL
age	NULL
>	NULL
20	NULL
and	NULL
<	NULL
40	NULL
years	NULL
)	NULL
showed	NULL
fewer	NULL
GR	NULL
in	NULL
MNL	NULL
than	NULL
did	NULL
group	NULL
A	NULL
(	NULL
age	NULL
<	NULL
20	NULL
:	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

Although	NULL
not	NULL
statistically	NULL
significant	NULL
,	NULL
groups	NULL
C	NULL
(	NULL
age	NULL
>	NULL
40	NULL
and	NULL
<	NULL
60	NULL
)	NULL
and	NULL
D	NULL
(	NULL
age	NULL
>	NULL
60	NULL
)	NULL
also	NULL
showed	NULL
relatively	NULL
fewer	NULL
GR	NULL
than	NULL
did	NULL
group	NULL
A	NULL
.	NULL

Gender	NULL
difference	NULL
was	NULL
unclear	NULL
in	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

The	NULL
range	NULL
of	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
in	NULL
86	NULL
men	NULL
was	NULL
3.3-13.3	NULL
fmol/10®	NULL
cells	NULL
(	NULL
8.7	NULL
+	NULL
2.8	NULL
)	NULL
,	NULL
and	NULL
in	NULL
59	NULL
women	NULL
was	NULL
2.5-16.4	NULL
fmol/10°	NULL
cells	NULL
(	NULL
8.1	NULL
+	NULL
3.0	NULL
)	NULL
.	NULL

Seasonal	NULL
variation	NULL
in	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
.	NULL

There	NULL
was	NULL
no	NULL
apparent	NULL
relationship	NULL
between	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
and	NULL
the	NULL
month	NULL
of	NULL
the	NULL
year	NULL
when	NULL
GR	NULL
were	NULL
determined	NULL
.	NULL

Down-regulation	NULL
of	NULL
GR	NULL
in	NULL
MNL	NULL
in	NULL
patients	NULL
undergoing	NULL
prednisolone	NULL
therapy	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
our	NULL
method	NULL
for	NULL
GR	NULL
determination	NULL
detected	NULL
down-regulation	NULL
of	NULL
GR	NULL
in	NULL
MNL	NULL
after	NULL
exogenous	NULL
administration	NULL
of	NULL
glucocorticoids	NULL
,	NULL
we	NULL
studied	NULL
eight	NULL
women	NULL
with	NULL
dermatomyositis/polymy-ogitis	NULL
.	NULL

Before	NULL
administration	NULL
of	NULL
synthetic	NULL
glucocorticoid	NULL
prednisolone	NULL
,	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
ranged	NULL
from	NULL
7.7	NULL
to	NULL
15.3	NULL
fmol/10®	NULL
cells	NULL
(	NULL
mean	NULL
10.7	NULL
,	NULL
SD	NULL
2.2	NULL
)	NULL
.	NULL

Initial	NULL
dosages	NULL
of	NULL
prednisolone	NULL
varied	NULL
from	NULL
40	NULL
to	NULL
60	NULL
mg/d	NULL
(	NULL
mean	NULL
54.9	NULL
,	NULL
SD	NULL
9.0	NULL
)	NULL
.	NULL

One	NULL
month	NULL
after	NULL
initiation	NULL
of	NULL
the	NULL
therapy	NULL
,	NULL
GR	NULL
were	NULL
determined	NULL
again	NULL
in	NULL
MNL	NULL
of	NULL
the	NULL
corresponding	NULL
patients	NULL
.	NULL

In	NULL
seven	NULL
of	NULL
eight	NULL
patients	NULL
,	NULL
the	NULL
GR	NULL
in	NULL
MNL	NULL
decreased	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
(	NULL
7.8	NULL
SD	NULL
154	NULL
.	NULL

K	NULL
r=-0.122	NULL
®	NULL
e	NULL
e	NULL
+	NULL
0	NULL
e-	NULL
*e	NULL
$	NULL
-	NULL
U	NULL
£	NULL
*	NULL
*	NULL
K3	NULL
60	NULL
e-	NULL
*	NULL
la	NULL
‘	NULL
u	NULL
10	NULL
2	NULL
...	NULL

.	NULL

'~o	NULL
.	NULL
'	NULL

P	NULL
*	NULL
a	NULL
.	NULL

£28	NULL
*e	NULL
``	NULL
t	NULL
in	NULL
s*	NULL
R	NULL
20°	NULL
T	NULL
*e	NULL
®	NULL
*	NULL
0	NULL
%	NULL
28	NULL
a	NULL
e	NULL
P	NULL
6	NULL
tut	NULL
>	NULL
®	NULL
&	NULL
52	NULL
Suss	NULL
*/	NULL
.	NULL

a~	NULL
s	NULL
B	NULL
gv	NULL
5	NULL
*e	NULL
*	NULL
®	NULL
LJ	NULL
é	NULL
®	NULL
F	NULL
‘	NULL
a	NULL
.	NULL

b	NULL
A	NULL
®	NULL
0	NULL
0	NULL
L	NULL
P	NULL
U	NULL
M-	NULL
T	NULL
r	NULL
t	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
Age	NULL
(	NULL
yr	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Relationship	NULL
between	NULL
age	NULL
and	NULL
GR	NULL
number	NULL
in	NULL
normal	NULL
human	NULL
Glucocorticoid	NULL
Receptors	NULL
MNL	NULL
Receptor	NULL
number	NULL
Ky	NULL
Mean	NULL
+	NULL
SD	NULL
,	NULL
CVv	NULL
,	NULL
Mean	NULL
+	NULL
SD	NULL
,	NULL
cv	NULL
,	NULL
Table	NULL
2	NULL
.	NULL

Effects	NULL
of	NULL
Age	NULL
on	NULL
GR	NULL
Number	NULL
in	NULL
MNL	NULL
Subject	NULL
tmol/10°	NULL
cells	NULL
%	NULL
nmol/L	NULL
%	NULL
GR	NULL
number	NULL
,	NULL
H.T	NULL
.	NULL

10.41	NULL
+	NULL
0.91	NULL
9.1	NULL
7.93	NULL
+	NULL
0.84	NULL
10.6	NULL
Group	NULL
n	NULL
Age	NULL
,	NULL
years	NULL
tmol/10°	NULL
cells	NULL
,	NULL
mean	NULL
+	NULL
SD	NULL
S.A.	NULL
9.08	NULL
+	NULL
0.06	NULL
0.6	NULL
715	NULL
+	NULL
0.31	NULL
4.4	NULL
A	NULL
13	NULL
<	NULL
20	NULL
11.4	NULL
+	NULL
2.4	NULL
D..	NULL
11.22	NULL
+	NULL
0.17	NULL
1.5	NULL
7.26	NULL
+	NULL
1.23	NULL
16.9	NULL
B	NULL
101	NULL
-	NULL
>	NULL
20	NULL
and	NULL
<	NULL
40	NULL
9.6	NULL
+	NULL
2.6*	NULL
H.O	NULL
.	NULL

10.37	NULL
+	NULL
2.71	NULL
26.1	NULL
6.31	NULL
+	NULL
2.47	NULL
39.2	NULL
C	NULL
20	NULL
-	NULL
>	NULL
40	NULL
and	NULL
<	NULL
60	NULL
8.5	NULL
+	NULL
2.8	NULL
D.M	NULL
.	NULL

9.75	NULL
+	NULL
1.13	NULL
11.6	NULL
8.07	NULL
+	NULL
0.67	NULL
8.3	NULL
D	NULL
11	NULL
>	NULL
60	NULL
7.9	NULL
+	NULL
2.6	NULL
n	NULL
=	NULL
5	NULL
assays	NULL
for	NULL
each	NULL
subject	NULL
.	NULL

*	NULL
P	NULL
<	NULL
0.05	NULL
vs	NULL
GR	NULL
number	NULL
in	NULL
group	NULL
A	NULL
.	NULL

1716	NULL
CLINICAL	NULL
CHEMISTRY	NULL
,	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

10	NULL
,	NULL
1991	NULL
157	NULL
X	NULL
.	NULL

U	NULL
s	NULL
i	NULL
t	NULL
a	NULL
&	NULL
«	NULL
»	NULL
_	NULL
§	NULL
10	NULL
go	NULL
&	NULL
&	NULL
5	NULL
%	NULL
&	NULL
2	NULL
8	NULL
j	NULL
<	NULL
x	NULL
6	NULL
|	NULL
2	NULL
&	NULL
B	NULL
l	NULL
5	NULL
:	NULL
54	NULL
i-6	NULL
i	NULL
E	NULL
\	NULL
Men	NULL
Women	NULL
(	NULL
N=	NULL
86	NULL
)	NULL
(	NULL
N=59	NULL
)	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Gender-related	NULL
differences	NULL
in	NULL
concentrations	NULL
of	NULL
GR	NULL
in	NULL
normal	NULL
human	NULL
MNL	NULL
Vertical	NULL
bar	NULL
represents	NULL
mean	NULL
+	NULL
SD	NULL
0	NULL
a	NULL
on	NULL
og	NULL
-	NULL
mee	NULL
gag	NULL
0	NULL
#	NULL
a	NULL
Number	NULL
®	NULL
U	NULL
Be	NULL
+	NULL
be	NULL
e	NULL
e	NULL
«	NULL
sofa	NULL
J-	NULL
Amjte®	NULL
+	NULL
DI	NULL
+	NULL
``	NULL
=a	NULL
t	NULL
so	NULL
o	NULL
@	NULL
pec	NULL
a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
U	NULL
6	NULL
1	NULL
U	NULL
U	NULL
to	NULL
11	NULL
1t	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Seasonal	NULL
variation	NULL
in	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
in	NULL
normal	NULL
human	NULL
MNL	NULL
1.6	NULL
)	NULL
was	NULL
significantly	NULL
lower	NULL
than	NULL
that	NULL
measured	NULL
before	NULL
therapy	NULL
(	NULL
P	NULL
<	NULL
0.02	NULL
,	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
the	NULL
hypothalamic-pituitary-adrenal	NULL
axis	NULL
on	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
.	NULL

In	NULL
33	NULL
healthy	NULL
subjects	NULL
(	NULL
22	NULL
men	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
relationship	NULL
between	NULL
concentrations	NULL
of	NULL
GR	NULL
in	NULL
MNL	NULL
and	NULL
those	NULL
of	NULL
plasma	NULL
cortisol	NULL
measured	NULL
in	NULL
the	NULL
morning	NULL
.	NULL

The	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
did	NULL
not	NULL
show	NULL
a	NULL
significant	NULL
relationship	NULL
with	NULL
morning	NULL
cortisol	NULL
concentrations	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

Plasma	NULL
cortisol	NULL
concentrations	NULL
are	NULL
well	NULL
known	NULL
to	NULL
show	NULL
circadian	NULL
variation-being	NULL
relatively	NULL
high	NULL
in	NULL
the	NULL
morning	NULL
and	NULL
low	NULL
in	NULL
the	NULL
evening	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

In	NULL
16	NULL
healthy	NULL
subjects	NULL
(	NULL
nine	NULL
men	NULL
)	NULL
,	NULL
blood	NULL
was	NULL
drawn	NULL
twice	NULL
(	NULL
0800	NULL
and	NULL
1800	NULL
h	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
two	NULL
additional	NULL
blood	NULL
samplings	NULL
15	NULL
min	NULL
after	NULL
each	NULL
sampling	NULL
.	NULL

MNL	NULL
and	NULL
plasma	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
the	NULL
GR	NULL
in	NULL
MNL	NULL
were	NULL
determined	NULL
without	NULL
delay	NULL
.	NULL

Plasma	NULL
cortisol	NULL
was	NULL
assayed	NULL
in	NULL
one	NULL
experiment	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6a	NULL
,	NULL
concentrations	NULL
of	NULL
plasma	NULL
cortisol	NULL
in	NULL
these	NULL
subjects	NULL
demonstrated	NULL
apparent	NULL
diurnal	NULL
variation	NULL
,	NULL
varying	NULL
from	NULL
537.6	NULL
nmol/L	NULL
(	NULL
mean	NULL
)	NULL
in	NULL
the	NULL
morning	NULL
to	NULL
299.6	NULL
nmol/L	NULL
in	NULL
the	NULL
evening	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
GR	NULL
did	NULL
not	NULL
show	NULL
marked	NULL
{	NULL
m+sD	NULL
20r	NULL
r	NULL
--	NULL
P	NULL
<	NULL
0.0	NULL
@	NULL
0	NULL
--	NULL
Receptor	NULL
Number	NULL
(	NULL
f	NULL
moles/10®	NULL
cells	NULL
)	NULL
o	NULL
n	NULL
t	NULL
--	NULL
-f-4	NULL
-t-	NULL
<	NULL
n	NULL
T	NULL
R	NULL
J	NULL
.	NULL

Before	NULL
After	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Changes	NULL
in	NULL
concentrations	NULL
of	NULL
GR	NULL
in	NULL
MNL	NULL
before	NULL
and	NULL
after	NULL
initiation	NULL
of	NULL
prednisolone	NULL
therapy	NULL
in	NULL
eight	NULL
patients	NULL
with	NULL
dermatomy-	NULL
ositis/	NULL
Vertical	NULL
bar	NULL
represents	NULL
mean	NULL
+	NULL
SD	NULL
@	NULL
o	NULL
.8	NULL
16F	NULL
o	NULL
®	NULL
o	NULL
$	NULL
14	NULL
o	NULL
o	NULL
e	NULL
bet	NULL
o	NULL
§	NULL
12	NULL
o	NULL
hes	NULL
e	NULL
®	NULL
&	NULL
e	NULL
%	NULL
o	NULL
*e	NULL
o	NULL
&	NULL
10	NULL
e	NULL
e	NULL
-*	NULL
e	NULL
R	NULL
3	NULL
2	NULL
8	NULL
&	NULL
o	NULL
3	NULL
®	NULL
e	NULL
2	NULL
5	NULL
bet	NULL
e	NULL
§	NULL
a	NULL
a	NULL
@	NULL
8	NULL
Gf	NULL
C	NULL
0	NULL
aat	NULL
a	NULL
mad	NULL
250	NULL
500	NULL
T50	NULL
Plasma	NULL
Cortisol	NULL
(	NULL
n	NULL
mol/L	NULL
)	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Relationship	NULL
between	NULL
concentrations	NULL
of	NULL
plasma	NULL
cortisol	NULL
and	NULL
GR	NULL
number	NULL
in	NULL
normal	NULL
human	NULL
MNL	NULL
variation	NULL
,	NULL
although	NULL
the	NULL
concentrations	NULL
of	NULL
GR	NULL
were	NULL
slightly	NULL
lower	NULL
in	NULL
the	NULL
morning	NULL
than	NULL
in	NULL
the	NULL
evening	NULL
(	NULL
10.3	NULL
+	NULL
2.5	NULL
and	NULL
11.6	NULL
+	NULL
2.6	NULL
fmol/10°	NULL
cells	NULL
,	NULL
respectively	NULL
;	NULL
Figure	NULL
6b	NULL
)	NULL
.	NULL

Discussion	NULL
Alterations	NULL
in	NULL
the	NULL
adoptive	NULL
responsiveness	NULL
to	NULL
hormones	NULL
are	NULL
age	NULL
related	NULL
,	NULL
as	NULL
are	NULL
changes	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
many	NULL
enzymes	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Glucocorticoid	NULL
hormone-mediated	NULL
responses	NULL
are	NULL
controlled	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
GR	NULL
,	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
hormone-receptor	NULL
complex	NULL
,	NULL
and	NULL
by	NULL
translocation	NULL
of	NULL
these	NULL
complexes	NULL
to	NULL
the	NULL
nuclear	NULL
acceptor	NULL
sites	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

There	NULL
have	NULL
been	NULL
various	NULL
reports	NULL
concerning	NULL
age-dependent	NULL
regulation	NULL
of	NULL
the	NULL
GR	NULL
in	NULL
animal	NULL
tissues	NULL
(	NULL
23-26	NULL
)	NULL
.	NULL

Currently	NULL
,	NULL
senescent	NULL
rats	NULL
are	NULL
thought	NULL
to	NULL
show	NULL
reduced	NULL
binding	NULL
capacity	NULL
for	NULL
glucocorticoids	NULL
in	NULL
spleen	NULL
and	NULL
liver	NULL
(	NULL
23-26	NULL
)	NULL
.	NULL

Because	NULL
development	NULL
and	NULL
aging	NULL
of	NULL
animals	NULL
may	NULL
partly	NULL
be	NULL
characterized	NULL
by	NULL
changes	NULL
in	NULL
the	NULL
responsiveness	NULL
of	NULL
tissues	NULL
or	NULL
cells	NULL
to	NULL
certain	NULL
hormone	NULL
modulators	NULL
(	NULL
22	NULL
)	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
humans	NULL
show	NULL
quantitative	NULL
changes	NULL
in	NULL
the	NULL
concentra-	NULL
CLINICAL	NULL
CHEMISTRY	NULL
,	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

10	NULL
,	NULL
1991	NULL
1717	NULL
(	NULL
a	NULL
)	NULL
]	NULL
m+so	NULL
Ken	NULL
$	NULL
.743.3	NULL
341.9	NULL
8:00	NULL
18:00	NULL
Clock	NULL
Time	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Diurnal	NULL
changes	NULL
in	NULL
concentrations	NULL
GR	NULL
number	NULL
in	NULL
normal	NULL
human	NULL
MNL	NULL
(	NULL
b	NULL
)	NULL
Vertical	NULL
bar	NULL
represents	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
plasma	NULL
cortisol	NULL
(	NULL
a	NULL
)	NULL
and	NULL
tions	NULL
of	NULL
GR	NULL
during	NULL
aging	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
relationship	NULL
between	NULL
age	NULL
and	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
was	NULL
not	NULL
significant	NULL
,	NULL
partly	NULL
because	NULL
of	NULL
nonuniform	NULL
distribution	NULL
of	NULL
the	NULL
subjects	NULL
by	NULL
age	NULL
.	NULL

However	NULL
,	NULL
younger	NULL
subjects	NULL
tended	NULL
to	NULL
have	NULL
relatively	NULL
more	NULL
GR	NULL
in	NULL
MNL	NULL
,	NULL
as	NULL
also	NULL
reported	NULL
for	NULL
rats	NULL
.	NULL

Plasma	NULL
cortisol	NULL
concentrations	NULL
reportedly	NULL
do	NULL
not	NULL
change	NULL
considerably	NULL
during	NULL
aging	NULL
(	NULL
27	NULL
)	NULL
;	NULL
thus	NULL
,	NULL
developmental	NULL
change	NULL
in	NULL
the	NULL
GR	NULL
number	NULL
probably	NULL
does	NULL
not	NULL
reciprocally	NULL
complement	NULL
the	NULL
age-related	NULL
changes	NULL
in	NULL
plasma	NULL
cortisol	NULL
concentrations	NULL
,	NULL
but	NULL
may	NULL
relate	NULL
to	NULL
some	NULL
other	NULL
aspects	NULL
of	NULL
human	NULL
development	NULL
and	NULL
aging	NULL
.	NULL

Gender	NULL
differences	NULL
in	NULL
the	NULL
distribution	NULL
and	NULL
regulation	NULL
of	NULL
GR	NULL
have	NULL
also	NULL
been	NULL
studied	NULL
in	NULL
rats	NULL
(	NULL
28	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
humans	NULL
.	NULL

The	NULL
GR	NULL
number	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
the	NULL
liver	NULL
are	NULL
lower	NULL
in	NULL
female	NULL
than	NULL
in	NULL
male	NULL
rats	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Humans	NULL
show	NULL
no	NULL
significant	NULL
gender	NULL
difference	NULL
in	NULL
plasma	NULL
cortisol	NULL
concentrations	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
the	NULL
present	NULL
study	NULL
also	NULL
showed	NULL
no	NULL
marked	NULL
difference	NULL
by	NULL
gender	NULL
in	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
in	NULL
MNL	NULL
.	NULL

Ovariectomy	NULL
increases	NULL
GR	NULL
concentrations	NULL
in	NULL
rats	NULL
,	NULL
presumably	NULL
by	NULL
abrogating	NULL
agonistic	NULL
activity	NULL
of	NULL
progesterone	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
to	NULL
explain	NULL
these	NULL
differences	NULL
between	NULL
rats	NULL
and	NULL
humans	NULL
,	NULL
we	NULL
must	NULL
consider	NULL
the	NULL
possibility	NULL
that	NULL
plasma	NULL
progesterone	NULL
may	NULL
also	NULL
influence	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
women	NULL
,	NULL
thus	NULL
masking	NULL
actual	NULL
gender	NULL
difference	NULL
in	NULL
GR	NULL
numbers	NULL
(	NULL
28	NULL
)	NULL
.	NULL

GR	NULL
are	NULL
down-regulated	NULL
by	NULL
their	NULL
cognate	NULL
ligands	NULL
(	NULL
10	NULL
,	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
administration	NULL
of	NULL
prednisolone	NULL
for	NULL
one	NULL
month	NULL
decreased	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
considerably	NULL
,	NULL
indicating	NULL
the	NULL
reciprocal	NULL
relationship	NULL
between	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
and	NULL
plasma	NULL
concentrations	NULL
of	NULL
prednisolone	NULL
.	NULL

However	NULL
,	NULL
morning	NULL
concentrations	NULL
of	NULL
cortisol	NULL
in	NULL
plasma	NULL
did	NULL
not	NULL
show	NULL
any	NULL
correlation	NULL
with	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
failed	NULL
to	NULL
demonstrate	NULL
significant	NULL
alterations	NULL
in	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
within	NULL
a	NULL
day	NULL
,	NULL
even	NULL
though	NULL
plasma	NULL
cortisol	NULL
showed	NULL
circadian	NULL
variation	NULL
.	NULL

Pardes	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
reported	NULL
that	NULL
urinary	NULL
excretion	NULL
of	NULL
170HCS	NULL
,	NULL
not	NULL
plasma	NULL
concentrations	NULL
of	NULL
morning	NULL
cortisol	NULL
,	NULL
correlated	NULL
with	NULL
the	NULL
GR	NULL
number	NULL
in	NULL
MNL	NULL
in	NULL
patients	NULL
with	NULL
Cushing	NULL
disease	NULL
as	NULL
determined	NULL
by	NULL
whole-cell	NULL
assay	NULL
.	NULL

Doe	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
reported	NULL
1718	NULL
CLINICAL	NULL
CHEMISTRY	NULL
,	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

10	NULL
,	NULL
1991	NULL
that	NULL
cytosolic	NULL
GR	NULL
reflected	NULL
the	NULL
circadian	NULL
variation	NULL
of	NULL
plasma	NULL
cortisol	NULL
,	NULL
but	NULL
that	NULL
whole-cell	NULL
receptors	NULL
did	NULL
not	NULL
change	NULL
markedly	NULL
within	NULL
a	NULL
day	NULL
.	NULL

Given	NULL
these	NULL
results	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
physiological	NULL
secretion	NULL
of	NULL
cortisol	NULL
is	NULL
hardly	NULL
sufficient	NULL
to	NULL
affect	NULL
the	NULL
concentrations	NULL
of	NULL
GR	NULL
within	NULL
a	NULL
day	NULL
,	NULL
in	NULL
comparison	NULL
with	NULL
therapeutic	NULL
concentrations	NULL
of	NULL
synthetic	NULL
glucocorticoid	NULL
prednisolone	NULL
.	NULL

From	NULL
a	NULL
methodological	NULL
viewpoint	NULL
,	NULL
cytosolic	NULL
GR	NULL
assay	NULL
eliminates	NULL
GR	NULL
translocated	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
which	NULL
are	NULL
already	NULL
exposed	NULL
to	NULL
and	NULL
activated	NULL
by	NULL
cortisol	NULL
,	NULL
and	NULL
may	NULL
reflect	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
remaining	NULL
in	NULL
the	NULL
cytosol	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
whole-cell	NULL
GR	NULL
assay	NULL
principally	NULL
detects	NULL
all	NULL
binding	NULL
sites	NULL
for	NULL
glucocorticoids	NULL
through	NULL
ideally	NULL
complete	NULL
exchange	NULL
of	NULL
the	NULL
ligands	NULL
,	NULL
whether	NULL
the	NULL
GR	NULL
are	NULL
in	NULL
the	NULL
cytosol	NULL
or	NULL
translocated	NULL
after	NULL
activation	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
cytosolic	NULL
GR	NULL
concentrations	NULL
may	NULL
represent	NULL
the	NULL
amount	NULL
of	NULL
ligand-free	NULL
receptor	NULL
,	NULL
which	NULL
promptly	NULL
fluctuates	NULL
after	NULL
activation	NULL
and	NULL
translocation	NULL
of	NULL
the	NULL
receptor	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
concentrations	NULL
of	NULL
whole-cell	NULL
GR	NULL
may	NULL
reflect	NULL
the	NULL
amount	NULL
of	NULL
available	NULL
receptor	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
relatively	NULL
constant	NULL
within	NULL
a	NULL
day	NULL
(	NULL
32	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
suggested	NULL
(	NULL
manuscript	NULL
submitted	NULL
)	NULL
that	NULL
the	NULL
GR	NULL
number	NULL
determined	NULL
by	NULL
whole-cell	NULL
assay	NULL
in	NULL
MNL	NULL
reflects	NULL
individual	NULL
responsiveness	NULL
to	NULL
glucocorticoids	NULL
in	NULL
vivo	NULL
(	NULL
9	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
Ja	NULL
)	NULL
in	NULL
healthy	NULL
humans	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
GR-hormone	NULL
response	NULL
relationship	NULL
is	NULL
reported	NULL
in	NULL
various	NULL
categories	NULL
of	NULL
diseases	NULL
,	NULL
in	NULL
which	NULL
the	NULL
GR	NULL
were	NULL
determined	NULL
by	NULL
whole-cell	NULL
assay	NULL
(	NULL
3-8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
individual	NULL
responsiveness	NULL
to	NULL
glucocorticoids	NULL
is	NULL
reflected	NULL
by	NULL
the	NULL
concentrations	NULL
of	NULL
whole-cell	NULL
GR	NULL
in	NULL
MNL	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
whole-cell	NULL
assay	NULL
of	NULL
GR	NULL
apparently	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
age	NULL
,	NULL
gender	NULL
,	NULL
season	NULL
,	NULL
or	NULL
physiological	NULL
secretion	NULL
of	NULL
cortisol	NULL
,	NULL
and	NULL
is	NULL
relevant	NULL
in	NULL
assessing	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
GR	NULL
number	NULL
and	NULL
clinical	NULL
sensitivity	NULL
to	NULL
glucocorticoid	NULL
therapy	NULL
.	NULL

Clearly	NULL
,	NULL
for	NULL
practical	NULL
application	NULL
,	NULL
we	NULL
should	NULL
examine	NULL
further	NULL
the	NULL
influence	NULL
of	NULL
diseases	NULL
and	NULL
concomitant	NULL
administration	NULL
of	NULL
other	NULL
therapeutic	NULL
drugs	NULL
on	NULL
GR	NULL
determination	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
to	NULL
H.T	NULL
.	NULL

from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Yamamoto	NULL
KR	NULL
.	NULL

Steroid	NULL
receptor	NULL
regulated	NULL
transcription	NULL
of	NULL
specific	NULL
genes	NULL
and	NULL
gene	NULL
networks	NULL
[	NULL
Review	NULL
]	NULL
.	NULL

Ann	NULL
Rev	NULL
Genet	NULL
1985	NULL
;	NULL
19:209-52	NULL
.	NULL

2	NULL
.	NULL

Gustafsson	NULL
J-A	NULL
,	NULL
Carlstedt-Duke	NULL
J	NULL
,	NULL
Poelhnger	NULL
L	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Biochem	NULL
istry	NULL
,	NULL
molecular	NULL
biology	NULL
,	NULL
and	NULL
physwlogy	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
[	NULL
Review	NULL
]	NULL
.	NULL

Endocr	NULL
Rev	NULL
1987	NULL
;	NULL
8:185-234	NULL
.	NULL

3	NULL
.	NULL

Thompson	NULL
EB	NULL
,	NULL
Smith	NULL
JR	NULL
,	NULL
Bourgeois	NULL
S	NULL
,	NULL
Harmon	NULL
J.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
human	NULL
leukemias	NULL
and	NULL
related	NULL
disorders	NULL
.	NULL

Klin	NULL
Wochenschr	NULL
1985	NULL
;	NULL
63:689-98	NULL
.	NULL

4	NULL
.	NULL

Stevens	NULL
J	NULL
,	NULL
Stevens	NULL
Y-W.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
human	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
:	NULL
quantitation	NULL
and	NULL
clinical	NULL
significance	NULL
.	NULL

In	NULL
:	NULL
Hollander	NULL
VP	NULL
,	NULL
ed	NULL
.	NULL

Hormonally	NULL
responsive	NULL
tumors	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Academic	NULL
Press	NULL
,	NULL
1985:156-84	NULL
.	NULL

5	NULL
.	NULL

Pardes	NULL
EM	NULL
,	NULL
de	NULL
Yampey	NULL
JW	NULL
,	NULL
Soto	NULL
RJ	NULL
,	NULL
Moses	NULL
DF	NULL
,	NULL
De	NULL
Nicola	NULL
AF	NULL
.	NULL

A	NULL
correlative	NULL
study	NULL
between	NULL
glucocorticoid	NULL
receptor	NULL
levels	NULL
in	NULL
human	NULL
mononuelear	NULL
leukocytes	NULL
and	NULL
biochemical	NULL
data	NULL
in	NULL
Cushing	NULL
's	NULL
disease	NULL
.	NULL

Acta	NULL
Endocrinol	NULL
(	NULL
Copenh	NULL
)	NULL
1989	NULL
;	NULL
120:55-61	NULL
.	NULL

6	NULL
.	NULL

Sasu	NULL
BI	NULL
,	NULL
Muhkin	NULL
NA	NULL
,	NULL
Lyashko	NULL
VN	NULL
,	NULL
Freldm	NULL
ML	NULL
Glueocorhtmd	NULL
receptor	NULL
and	NULL
prognosis	NULL
of	NULL
the	NULL
effectiveness	NULL
of	NULL
glucocorticoid	NULL
treatment	NULL
in	NULL
nephritis	NULL
.	NULL

Klin	NULL
Med	NULL
(	NULL
Moscow	NULL
)	NULL
1984	NULL
;	NULL
62:75-9	NULL
.	NULL

7	NULL
.	NULL

Gormley	NULL
GJ	NULL
,	NULL
Lowy	NULL
MT	NULL
,	NULL
Reder	NULL
AT	NULL
,	NULL
Hospekhorn	NULL
VD	NULL
,	NULL
Antel	NULL
JP	NULL
,	NULL
Meltzer	NULL
HY	NULL
.	NULL

Glucocorticoid	NULL
receptors	NULL
in	NULL
depression	NULL
:	NULL
relationship	NULL
to	NULL
the	NULL
dexamethasone	NULL
suppression	NULL
test	NULL
.	NULL

Am	NULL
J	NULL
Psychiatry	NULL
1985	NULL
;	NULL
142	NULL
:	NULL
1278-84	NULL
.	NULL

8	NULL
.	NULL

Kontula	NULL
K	NULL
,	NULL
Myllyla	NULL
G	NULL
,	NULL
Andersson	NULL
LC	NULL
.	NULL

Glucocorticoid	NULL
receptors	NULL
in	NULL
adrenocorticoid	NULL
disorders	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
1980	NULL
;	NULL
51	NULL
:	NULL
654-7	NULL
.	NULL

9	NULL
.	NULL

Tanaka	NULL
H	NULL
,	NULL
Ichikawa	NULL
Y	NULL
,	NULL
Akama	NULL
H	NULL
,	NULL
Homma	NULL
M.	NULL
In	NULL
vivo	NULL
responsiveness	NULL
to	NULL
glucocorticoids	NULL
correlated	NULL
with	NULL
glucocorticoid	NULL
receptor	NULL
content	NULL
in	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
in	NULL
normal	NULL
humans	NULL
.	NULL

Acta	NULL
Endocrinol	NULL
(	NULL
Copenh	NULL
)	NULL
1989	NULL
;	NULL
121:470-6	NULL
.	NULL

9a	NULL
.	NULL

Tanaka	NULL
H	NULL
,	NULL
Akama	NULL
H	NULL
,	NULL
Ichikawa	NULL
Y	NULL
,	NULL
Homma	NULL
M	NULL
,	NULL
Makino	NULL
I.	NULL
Glucocorticoid	NULL
receptor	NULL
and	NULL
inhibition	NULL
of	NULL
3-O-methyl-D-glucose	NULL
uptake	NULL
by	NULL
glucocorticoids	NULL
in	NULL
peripheral	NULL
blood	NULL
1	NULL
:	NULL
in	NULL
normal	NULL
humans	NULL
:	NULL
correlation	NULL
between	NULL
receptor	NULL
levels	NULL
and	NULL
hormone	NULL
effect	NULL
in	NULL
vitro	NULL
.	NULL

Acta	NULL
Endocrinol	NULL
(	NULL
in	NULL
press	NULL
)	NULL
.	NULL

10	NULL
.	NULL

Shipmann	NULL
GF	NULL
,	NULL
Bloomfield	NULL
CD	NULL
,	NULL
Gaji-Peczalska	NULL
KJ	NULL
,	NULL
Munck	NULL
A	NULL
,	NULL
Smith	NULL
K.	NULL
GlucoeorhemdaandlymphwytuMEﬂ'ecuofglucoeor	NULL
ticoid	NULL
administration	NULL
on	NULL
lymphocytes	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Blood	NULL
1983	NULL
;	NULL
61:1986-90	NULL
.	NULL

11	NULL
.	NULL

Doe	NULL
RP	NULL
,	NULL
Goldman	NULL
PM	NULL
,	NULL
Severson	NULL
SP	NULL
,	NULL
Hruby	NULL
H.	NULL
Circadian	NULL
variation	NULL
of	NULL
cytosol	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
human	NULL
polymorpho-nuclear	NULL
le	NULL
(	NULL
PMN	NULL
)	NULL
and	NULL
mononuclear	NULL
cells	NULL
(	NULL
MN	NULL
)	NULL
in	NULL
a	NULL
normal	NULL
population	NULL
.	NULL

J	NULL
Steroid	NULL
Biochem	NULL
1986	NULL
;	NULL
25:483-7	NULL
.	NULL

12	NULL
.	NULL

Junker	NULL
K.	NULL
Glucocorticoid	NULL
of	NULL
human	NULL
mononuclear	NULL
leukocytes	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
1983	NULL
;	NULL
54:506-12	NULL
.	NULL

13	NULL
.	NULL

Lippman	NULL
H	NULL
,	NULL
Barr	NULL
R.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
purified	NULL
sub	NULL
populations	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
.	NULL

J	NULL
Immunol	NULL
1977	NULL
;	NULL
118:1977-81	NULL
.	NULL

14	NULL
.	NULL

Steiner	NULL
AE	NULL
,	NULL
Wittliff	NULL
JL	NULL
.	NULL

Concentration	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
sites	NULL
in	NULL
normal	NULL
human	NULL
lymphocytes	NULL
.	NULL

Clin	NULL
Chem	NULL
1986	NULL
;	NULL
32:80-3	NULL
.	NULL

15	NULL
.	NULL

Neifeld	NULL
JP	NULL
,	NULL
Lippman	NULL
ME	NULL
,	NULL
Tormey	NULL
DC	NULL
.	NULL

Steroid	NULL
hormone	NULL
receptors	NULL
in	NULL
normal	NULL
human	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
1977	NULL
;	NULL
252:2972-7	NULL
.	NULL

16	NULL
.	NULL

Tida	NULL
S	NULL
,	NULL
Gomi	NULL
M	NULL
,	NULL
Moriwaki	NULL
K	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Primary	NULL
cortisol	NULL
resistance	NULL
accompanied	NULL
by	NULL
a	NULL
reduction	NULL
in	NULL
glucocorticoid	NULL
in	NULL
two	NULL
members	NULL
of	NULL
the	NULL
same	NULL
family	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
1985	NULL
;	NULL
60:967-71	NULL
.	NULL

17	NULL
.	NULL

Scatchard	NULL
G.	NULL
The	NULL
attraction	NULL
of	NULL
proteins	NULL
for	NULL
small	NULL
molecules	NULL
and	NULL
ions	NULL
.	NULL

Ann	NULL
NY	NULL
Acad	NULL
Sci	NULL
1941	NULL
;	NULL
51:660-72	NULL
.	NULL

18	NULL
.	NULL

Kawai	NULL
S	NULL
,	NULL
Ichikawa	NULL
Y	NULL
,	NULL
Homma	NULL
M.	NULL
Differences	NULL
in	NULL
metabolic	NULL
properties	NULL
among	NULL
cortisol	NULL
,	NULL
prednisolone	NULL
,	NULL
and	NULL
dexamethasone	NULL
in	NULL
liver	NULL
and	NULL
renal	NULL
diseases	NULL
:	NULL
accelerated	NULL
metabolism	NULL
of	NULL
dexamethasone	NULL
in	NULL
renal	NULL
failure	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
1985	NULL
;	NULL
60:848-54	NULL
.	NULL

19	NULL
.	NULL

Goldstein	NULL
A.	NULL
Biostatistics	NULL
:	NULL
an	NULL
introductory	NULL
text	NULL
.	NULL

New	NULL
York	NULL
:	NULL
i	NULL
1967:129-87	NULL
.	NULL

20	NULL
.	NULL

Helman	NULL
L	NULL
,	NULL
Nakada	NULL
F	NULL
,	NULL
Curti	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cortisol	NULL
is	NULL
secreted	NULL
epmodleaﬂymnormalmmJ	NULL
Clin	NULL
Endomnollletablﬂ'm'm'ul—	NULL
21	NULL
Krieger	NULL
DT	NULL
,	NULL
Allen	NULL
W	NULL
,	NULL
Rizzo	NULL
F	NULL
,	NULL
Krieger	NULL
HP	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
normal	NULL
pattern	NULL
of	NULL
the	NULL
plasma	NULL
cortisol	NULL
levels	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
1971	NULL
;	NULL
32:266-84	NULL
.	NULL

22	NULL
.	NULL

Kanungo	NULL
MS	NULL
,	NULL
Biochemistry	NULL
of	NULL
aging	NULL
:	NULL
changes	NULL
in	NULL
enzymes	NULL
during	NULL
aging	NULL
.	NULL

London	NULL
:	NULL
Academic	NULL
Press	NULL
,	NULL
1980-79—126	NULL
23	NULL
.	NULL

Shanna	NULL
R	NULL
,	NULL
Timiras	NULL
PS	NULL
.	NULL

t	NULL
tion	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
the	NULL
liver	NULL
of	NULL
rats	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1987	NULL
;	NULL
930:287-48	NULL
.	NULL

24	NULL
.	NULL

Roth	NULL
GS	NULL
.	NULL

Reduced	NULL
glucocorticoid	NULL
responsiveness	NULL
and	NULL
receptor	NULL
concentration	NULL
in	NULL
splenic	NULL
leukocytes	NULL
of	NULL
senescent	NULL
rats	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1975	NULL
;	NULL
,399:145-56	NULL
.	NULL

25	NULL
.	NULL

KahmMGlmhcddmmﬁ'omdenlopmtwag-	NULL
ing	NULL
.	NULL

Mech	NULL
Aging	NULL
Dev	NULL
1984	NULL
;	NULL
24:129-38	NULL
.	NULL

26	NULL
.	NULL

Kalimi	NULL
M	NULL
,	NULL
Gupta	NULL
S	NULL
,	NULL
Hubbard	NULL
J	NULL
,	NULL
Greene	NULL
K.	NULL
Glucocorticoid	NULL
mepmmadultandaeneoeentrathver	NULL
Endocrinology	NULL
1983	NULL
;	NULL
112	NULL
:	NULL
841-7	NULL
.	NULL

27	NULL
.	NULL

West	NULL
CD	NULL
,	NULL
BmwnH	NULL
,	NULL
SxmonaEL	NULL
,	NULL
CartarDB	NULL
KumaguLI	NULL
``	NULL
Englert	NULL
E.	NULL
Adrenocortical	NULL
function	NULL
and	NULL
cortisol	NULL
metabolism	NULL
in	NULL
old	NULL
age	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
1961	NULL
;	NULL
21:1197-207	NULL
.	NULL

28	NULL
.	NULL

Endres	NULL
DB	NULL
,	NULL
Milholland	NULL
RJ	NULL
,	NULL
Rosen	NULL
F.	NULL
Sex	NULL
differences	NULL
in	NULL
the	NULL
concentrations	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
rat	NULL
liver	NULL
and	NULL
thymus	NULL
.	NULL

J	NULL
Endocrinol	NULL
1979	NULL
;	NULL
80:21-6	NULL
.	NULL

29	NULL
.	NULL

Schoneshofer	NULL
M	NULL
,	NULL
Wagner	NULL
GG	NULL
.	NULL

Sex	NULL
differences	NULL
in	NULL
corticosteroids	NULL
in	NULL
man	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
1977	NULL
;	NULL
45:814-7	NULL
.	NULL

30	NULL
.	NULL

Svec	NULL
F.	NULL
Glucocorticoid	NULL
receptor	NULL
regulation	NULL
.	NULL

Life	NULL
Sci	NULL
1985	NULL
;	NULL
36:2359-66	NULL
.	NULL

31	NULL
.	NULL

Schlechte	NULL
JA	NULL
,	NULL
Ginsberg	NULL
BH	NULL
,	NULL
Sherman	NULL
BM	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

J	NULL
Steroid	NULL
Biochem	NULL
1982	NULL
;	NULL
16:69-74	NULL
.	NULL

82	NULL
.	NULL

McIntyre	NULL
WR	NULL
,	NULL
Samuels	NULL
HH	NULL
.	NULL

Triamcinolone	NULL
acetonide	NULL
regu-	NULL
lates	NULL
glucocorticoid-receptor	NULL
levels	NULL
by	NULL
decreasing	NULL
the	NULL
half-life	NULL
of	NULL
the	NULL
activated	NULL
nuclear-receptor	NULL
form	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
1985	NULL
;	NULL
260:418-	NULL
27	NULL
.	NULL

CLINICAL	NULL
CHEMISTRY	NULL
,	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

10	NULL
,	NULL
1991	NULL
1719	NULL

